Five-year outcomes of CD19 followed by CD22 chimeric antigen receptor T-cell therapy in B-cell acute lymphoblastic leukemia patients who relapsed after allo-transplantation

Authors

Tong Wu (ORCID: https://orcid.org/0000-0002-1152-3128)
Zhichao Yin (ORCID: https://orcid.org/0000-0003-1853-0272)
Alex H. Chang (ORCID: https://orcid.org/0000-0002-7572-309X)
Zhuojun Ling
Defeng Zhao
Shuangyou Liu (ORCID: https://orcid.org/0000-0001-9982-7099)
Yuehui Lin
Xinjian Yu (ORCID: https://orcid.org/0000-0002-6279-1544)
Biping Deng (ORCID: https://orcid.org/0000-0002-3244-9174)
Chunrong Tong
Qinlong Zheng (ORCID: https://orcid.org/0000-0002-8433-3691)
Lihong An

Institutions

Beijing Tongren Hospital (CN)
Beijing United Family Hospital (CN)
Beike Biotechnology (China) (CN)
BorgWarner (Brazil) (BR)

Publication Details

Journal: Haematologica
Published: 2024-12-12
DOI: https://doi.org/10.3324/haematol.2024.286534
Citations: 2
Primary Topic: CAR-T cell therapy research
Type: article
Field-Weighted Citation Impact: 0.57

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Five-year outcomes of CD19 followed by CD22 chimeric antigen receptor T-cell therapy in B-cell acute lymphoblastic leukemia patients who relapsed after allo-transplantation

Tong Wu, Zhichao Yin, Alex H. Chang, Zhuojun Ling et al.

Dec 12, 2024

2 citations

Haematologica

CAR-T cell therapy research

0.57

article

Five-year outcomes of CD19 followed by CD22 chimeric antigen receptor T-cell therapy in B-cell acute lymphoblastic leukemia patients who relapsed after allo-transplantation

Tong Wu, Zhichao Yin, Alex H. Chang, Zhuojun Ling, Defeng Zhao, Shuangyou Liu, Yuehui Lin, Xinjian Yu, Biping Deng, Chunrong Tong, Qinlong Zheng, Lihong An

December 12, 2024article en

2 citations

Abstract

No abstract available for this paper.

HaematologicaVol. 110(5)

Beijing Tongren Hospital (CN), Beijing United Family Hospital (CN), Beike Biotechnology (China) (CN), BorgWarner (Brazil) (BR)

Good health and well-being

Openalex Percentile: Top 26%

CAR-T cell therapy research

0.57

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Five-year outcomes of CD19 followed by CD22 chimeric antigen receptor T-cell therapy in B-cell acute lymphoblastic leukemia patients who relapsed after allo-transplantation — Tong Wu, Zhichao Yin, et al. · Haematologica (2024) | TGRS Research Map | TGRS